Patent · US Active

Dosage form

USD1071139S1 · kind S1 · design

0Cited by
51References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 13, 2023
Grant dateApr 15, 2025
Priority date
Expiry dateApr 15, 2040

Classification

  • Technology area (CPC —)General

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.